SELLAS Life Sciences Group (SLS) Analyst & Key Data

Analyst Consensus

Buy5 analysts

Buy

Updated Sep 12, 2026

Total Analysts5

Buy

5

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$11.55

DCF Value-94.57%

$0.63

Potential downside vs current price

Current Stock Price

$11.55

DCF Value-94.57%

$0.63

Potential downside vs current price

Analyst Consensus

Buy5 analysts

Buy

Updated Sep 12, 2026

Total Analysts5

Buy

5

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score3.0 / 5

Debt / Equity Score4.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$11.55

DCF Value-94.57%

$0.63

Potential downside vs current price

Current Stock Price

$11.55

DCF Value-94.57%

$0.63

Potential downside vs current price

SELLAS Life Sciences Group, Inc.